Brian Burke is a partner in the Litigation practice. He has conducted dozens of investigations throughout Asia Pacific, including in Greater China (Mainland China, Hong Kong, Taiwan), Japan, South Korea, India, Singapore, Indonesia, Thailand, Malaysia, Vietnam, Australia and New Zealand. As a fluent Mandarin speaker, Mr. Burke has a particular focus on advising multinationals with operations in China in the areas of FCPA/anti-corruption, economic sanctions, antitrust, shareholder litigation, anti-money laundering and other compliance and investigative matters. A client describes him as simply outstanding,” further commenting that he is one of the best outside counsels I have ever worked with. Clients also describe Mr. Burke as a “very, very skillful communicator, including at board level” and note that his “language and passion for Chinese culture are unique.”

Mr. Burke acted as lead advisor to GlaxoSmithKline on the landmark bribery case against GSK in China, the first such case against a foreign company in China. Subsequently, Crown Resorts retained Mr. Burke to help resolve the widely-publicized criminal charges against Crown employees for gambling-related crimes in China. Mr. Burke has also represented Chinese, Japanese, European and North American clients on investigations and compliance matters throughout Asia, including McDonald’s, Olympus, LVMH, Medtronic, Roche, PetroChina, Sinopec, Volvo, Sephora, Valeo and others.

Mr. Burke has appeared before the U.S. Department of Justice, U.S. Securities and Exchange Commission, UK Serious Fraud Office, Hong Kong Securities and Futures Commission, Hong Kong Independent Commission Against Corruption, and other international regulators on cross-border investigations and compliance matters.